[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 17 of about 17
1. Duhan N, Singh S, Kadian YS, Duhan U, Rajotia N, Sangwan N: Primary leiomyosarcoma of broad ligament: case report and review of literature. Arch Gynecol Obstet; 2009 May;279(5):705-8
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary leiomyosarcoma of broad ligament: case report and review of literature.
  • INTRODUCTION: Primary leiomyosarcoma of the broad ligament (LBL) is a very rare and highly malignant gynecological tumor.
  • MATERIALS AND METHODS: A 45 year old hysterectomized woman with this rare tumor is presented.
  • Treatment consisted of resection of the tumor along with omental and peritoneal sampling and adjuvant chemotherapy.
  • CONCLUSION: Complete surgery along with adjuvant chemotherapy or radiation and a close follow up for recurrence are advocated to optimize disease free survival.
  • [MeSH-major] Broad Ligament / pathology. Leiomyosarcoma / pathology
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Combined Modality Therapy. Cyclophosphamide / administration & dosage. Dactinomycin / administration & dosage. Female. Gynecologic Surgical Procedures. Humans. Middle Aged. Vincristine / administration & dosage

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. DACTINOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18777035.001).
  • [ISSN] 1432-0711
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 1CC1JFE158 / Dactinomycin; 5J49Q6B70F / Vincristine; 8N3DW7272P / Cyclophosphamide
  • [Number-of-references] 27
  •  go-up   go-down


2. Itani Y, Itoh K, Adachi S, Koyama M, Kimura T, Chin R, Takemura T: Malignant epithelial tumor of unknown origin of the broad ligament. Arch Gynecol Obstet; 2002 Dec;267(2):113-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant epithelial tumor of unknown origin of the broad ligament.
  • Malignant epithelial tumor of the broad ligament is rare and to our knowledge only 17 cases have been reported.
  • We report a 54-year-old Japanese woman in whom transvaginal sonography (TVS) and magnetic resonance imaging (MRI) showed a left adnexal tumor.
  • Preoperatively, we diagnosed this tumor was a left ovarian malignant tumor though, it was confirmed a the 47x57 mm tumor in the left broad ligament at laparotomy.
  • Histologically most of the tumor showed serous papillary adenocarcinoma with changes similar to poorly differentiated carcinoma and as seen in transitional cell carcinoma on hematoxylin-eosin staining.
  • After three courses of platinum based adjuvant chemotherapy, the patient is alive with no recurrence at 18 months postoperatively.
  • [MeSH-major] Broad Ligament. Cystadenocarcinoma, Papillary / pathology. Genital Neoplasms, Female / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12439561.001).
  • [ISSN] 0932-0067
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 9
  •  go-up   go-down


3. Kolusari A, Ugurluer G, Kosem M, Kurdoglu M, Yildizhan R, Adali E: Leiomyosarcoma of the broad ligament: a case report and review of the literature. Eur J Gynaecol Oncol; 2009;30(3):332-4
Genetic Alliance. consumer health - Leiomyosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyosarcoma of the broad ligament: a case report and review of the literature.
  • Leiomyosarcoma of the broad ligament is a rare tumour, since only 15 cases have been reported thus far in the English literature.
  • We describe the case of a 35-year-old patient with primary leiomyosarcoma of the broad ligament.
  • The histologic diagnosis and management of this rapidly progressive and highly malignant tumour are also discussed.
  • The tumor had high mitotic activity and more than ten mitotic figures were found for ten high-power fields.
  • The treatment consisted of total abdominal hysterectomy, bilateral salpingo-oophorectomy and pelvic lymph node dissection.
  • The patient received pelvic radiotherapy and chemotherapy considering the high grade of malignancy.
  • [MeSH-major] Broad Ligament. Genital Neoplasms, Female / diagnosis. Leiomyosarcoma / diagnosis
  • [MeSH-minor] Adnexal Diseases / diagnosis. Adnexal Diseases / pathology. Adult. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19697635.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


Advertisement
4. Nagar YS, Singh S, Sawlani V, Pal L, Dimri K, Lal P: Primary papillary serous cystadenocarcinoma of broad ligament. Australas Radiol; 2005 Apr;49(2):160-2
Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary papillary serous cystadenocarcinoma of broad ligament.
  • A rare case of an advanced primary broad ligament carcinoma is discussed, with a review of the literature regarding its incidence, presentation and management.
  • This patient showed a complete response to adjuvant cisplatin-based chemotherapy following panhysterectomy and is presently without any evidence of disease, 15 months after completion of her treatment.
  • [MeSH-major] Broad Ligament. Cystadenocarcinoma, Papillary / surgery. Genital Neoplasms, Female / surgery
  • [MeSH-minor] Antineoplastic Agents / therapeutic use. Chemotherapy, Adjuvant. Cisplatin / therapeutic use. Diagnosis, Differential. Female. Humans. Hysterectomy. Middle Aged. Photomicrography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Papillary cystadenocarcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15845057.001).
  • [ISSN] 0004-8461
  • [Journal-full-title] Australasian radiology
  • [ISO-abbreviation] Australas Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Antineoplastic Agents; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


5. Murialdo R, Usset A, Guido T, Carli F, Boccardo F, Amoroso D: Leiomyosarcoma of the broad ligament: a case report and review of literature. Int J Gynecol Cancer; 2005 Nov-Dec;15(6):1226-9
Genetic Alliance. consumer health - Leiomyosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyosarcoma of the broad ligament: a case report and review of literature.
  • Leiomyosarcoma of the broad ligament is a rare tumor, since only 12 cases have been reported so far in the literature.
  • A 53-year-old patient was diagnosed with leiomyosarcoma of the broad ligament at the Department of Gynecology Oncology of the National Cancer Research Institute in Genoa.
  • The tumor had low mitotic activity and less than ten mitotic figures were found for ten high-power fields.
  • The treatment consisted of total abdominal hysterectomy and bilateral salpingo-oophorectomy with bilateral ureteral neoanastomosis and omentectomy.
  • The patient has not received either radiotherapy or chemotherapy, considering the low grade of malignancy, but she is only followed up on an outpatient basis.
  • It is concluded that low-grade leiomyosarcoma of the broad ligament should be treated only with surgery.
  • [MeSH-minor] Broad Ligament. Female. Gynecologic Surgical Procedures. Humans. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16343220.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 17
  •  go-up   go-down


6. Mrad K, Driss M, Abdelmoula S, Sassi S, Hechiche M, Ben Romdhane K: Primary broad ligament cystadenocarcinoma with mucinous component: a case report with immunohistochemical study. Arch Pathol Lab Med; 2005 Feb;129(2):244-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary broad ligament cystadenocarcinoma with mucinous component: a case report with immunohistochemical study.
  • Primary cystadenocarcinoma that arises in the broad ligament is extremely rare, especially when it is mucinous.
  • We report the case of a 59-year-old woman with a cystic mass of the right broad ligament who underwent a complete excision of the mass (7 x 7 x 3 cm) with hysterectomy, right salpingo-oophorectomy, omentectomy, appendicectomy, and peritoneal biopsies.
  • Pathologic examination showed a low-grade cystadenocarcinoma with a mucinous component limited to the broad ligament.
  • Despite the chemotherapy (cisplatinum and cyclophosphamide) performed, early tumor recurrence occurred after approximately 6 months.
  • [MeSH-major] Broad Ligament / pathology. Cystadenocarcinoma, Mucinous / diagnosis. Immunohistochemistry / methods. Urogenital Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15679432.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / KRT7 protein, human; 0 / Keratin-7; 0 / Mucin-1; 68238-35-7 / Keratins
  •  go-up   go-down


7. Clarke BA, Rahimi K, Chetty R: Leiomyosarcoma of the broad ligament with osteoclast-like giant cells and rhabdoid cells. Int J Gynecol Pathol; 2010 Sep;29(5):432-7
Genetic Alliance. consumer health - Leiomyosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyosarcoma of the broad ligament with osteoclast-like giant cells and rhabdoid cells.
  • In this report we document an unusual co-mingling of rhabdoid and osteoclast like giant cells in a leiomyosarcoma arising from the broad ligament.
  • The tumor now showed a prominent population of both osteoclast-like giant cells and rhabdoid cells.
  • Interestingly, the immunophenotype of the tumor had also changed with complete loss of desmin, caldesmon and only focal expression of smooth muscle actin.
  • This tumor was characterized by rapid clinical progression despite extensive surgery and chemotherapy.
  • These two cells types have individually been implicated as harbingers of a poor prognosis in leiomyosarcomas.
  • Their prominence in the recurrent tumor and the loss of muscle marker expression are in keeping with biologic progression.
  • [MeSH-major] Broad Ligament / pathology. Giant Cells / pathology. Leiomyosarcoma / pathology. Osteoclasts / pathology. Peritoneal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20736768.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


8. Milam MR, Gabel SF, Milam RA, Liu J, Ramirez PT: Neoadjuvant bleomycin, etoposide, and cisplatin in adult neuroblastoma arising from the broad ligament of the uterus. Gynecol Oncol; 2007 Nov;107(2):350-4
Hazardous Substances Data Bank. ETOPOSIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neoadjuvant bleomycin, etoposide, and cisplatin in adult neuroblastoma arising from the broad ligament of the uterus.
  • BACKGROUND: A case of primary neuroblastoma arising from the broad ligament with excellent response to neoadjuvant bleomycin, etoposide, and cisplatin (BEP) is reported.
  • CASE: A 48-year-old woman, G0, who presented with acute renal failure, an enlarged pelvic mass, and abdominal pain was diagnosed with adult neuroblastoma arising from the broad ligament of the uterus.
  • She received three cycles of neoadjuvant therapy consisting of bleomycin, etoposide, and cisplatin (BEP) given every 3 weeks and had an excellent initial response.
  • She then underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and appendectomy, with pathologic analysis revealing small residual disease on the broad ligament of the uterus and omentum.
  • The patient died of recurrent disease 20 months after her initial diagnosis.
  • CONCLUSIONS: The clinical management of cancer in the broad ligament of the uterus must be tailored to the pathologic diagnosis.
  • Although our patient had an excellent initial response to BEP, further study is needed to identify a treatment that can reduce recurrences and improve clinical outcomes.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Broad Ligament. Neoadjuvant Therapy / methods. Neuroblastoma / drug therapy. Neuroblastoma / surgery. Uterine Neoplasms / drug therapy. Uterine Neoplasms / surgery
  • [MeSH-minor] Bleomycin / administration & dosage. Cisplatin / administration & dosage. Etoposide / administration & dosage. Female. Humans. Middle Aged. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17881040.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 11056-06-7 / Bleomycin; 6PLQ3CP4P3 / Etoposide; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


9. Seoud M, Cheaib S, Birjawi G, Tawil A, Jamali F: Successful treatment of severe retro-peritoneal bleeding with recombinant factor VIIa in women with placenta percreta invading into the left broad ligament: unusual repeated ante-partum intra-abdominal bleeding. J Obstet Gynaecol Res; 2010 Feb;36(1):183-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful treatment of severe retro-peritoneal bleeding with recombinant factor VIIa in women with placenta percreta invading into the left broad ligament: unusual repeated ante-partum intra-abdominal bleeding.
  • We experienced unusual repeated ante-partum intra-abdominal bleedings in a woman with placenta percreta invading into the left broad ligament, in whom recombinant factor VIIa was effective for controlling severe retro-peritoneal bleeding.
  • She also represented with abdominal pain without vaginal bleeding at 27 weeks of gestation, and an MRI revealed a hematoma in the lower abdomino-pelvic region and placenta percreta invading into the left broad ligament.
  • [MeSH-major] Coagulants / therapeutic use. Factor VIIa / therapeutic use. Hematoma / drug therapy. Hemoperitoneum / drug therapy. Placenta Accreta. Pregnancy Complications, Cardiovascular / drug therapy. Retroperitoneal Space
  • [MeSH-minor] Adult. Broad Ligament. Female. Humans. Myometrium / pathology. Pregnancy. Pregnancy Trimester, Second. Recombinant Proteins / therapeutic use. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20178548.001).
  • [ISSN] 1447-0756
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Coagulants; 0 / Recombinant Proteins; 0 / recombinant FVIIa; EC 3.4.21.21 / Factor VIIa
  •  go-up   go-down


10. Corusic A, Barisic D, Lovric H, Despot A, Planinic P: Successful laparoscopic bipolar coagulation of a large arteriovenous malformation due to invasive trophoblastic disease: a case report. J Minim Invasive Gynecol; 2009 May-Jun;16(3):368-71
Hazardous Substances Data Bank. METHOTREXATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful laparoscopic bipolar coagulation of a large arteriovenous malformation due to invasive trophoblastic disease: a case report.
  • We report the case of an acquired large arteriovenous malformation due to invasive gestational trophoblastic tumor that was treated successfully with laparoscopic surgery.
  • After 4 cycles of methotrexate chemotherapy, a vascular tangle (volume, 28 cm(3)) was noted that emerged from the right uterine horn, invading the broad ligament adjacent to the uterine artery.
  • Doppler ultrasonography along with magnetic resonance arteriography confirmed the diagnosis.
  • Laparoscopy was performed, and bipolar coagulation of the ovarian and uterine artery feeding branches was achieved after surgical resection of the tumor.
  • The patient underwent chemotherapy, and at 2-month follow-up was cured and has since had regular menstrual cycles.
  • [MeSH-minor] Adult. Antimetabolites, Antineoplastic / therapeutic use. Female. Humans. Hysterotomy. Methotrexate / therapeutic use. Ovary / blood supply. Pregnancy. Uterus / blood supply

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19423071.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; YL5FZ2Y5U1 / Methotrexate
  •  go-up   go-down


11. Steed H, Oza A, Chapman WB, Yaron M, De Petrillo D: Female adnexal tumor of probable wolffian origin: a clinicopathological case report and a possible new treatment. Int J Gynecol Cancer; 2004 May-Jun;14(3):546-50
Genetic Alliance. consumer health - Wolffian tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Female adnexal tumor of probable wolffian origin: a clinicopathological case report and a possible new treatment.
  • Female adnexal tumors of probable wolffian origin (FATWOs) are rare tumors arising in the broad ligament from the remnants of the mesonephric duct.
  • A 15-year-old girl who presented with a painful pelvic mass underwent a laparotomy with tumor resection.
  • The tumor recurred within 2 years and was treated with multiple chemotherapy regimens, including a platinum-based drug, and surgery for progressive disease.
  • The tumor was positive for c-kit oncogene (CD 117).
  • Gleevac therapy, a tyrosine kinase inhibitor, was prescribed, and she developed severe persistent lower abdominal pain 2 months later.
  • Pathology showed evidence of tumor necrosis, suggesting a possible beneficial effect, and she was recommenced on Gleevac in an effort to prevent recurrences.
  • She is currently asymptomatic, without evidence of disease 10 months after surgery, continuing on Gleevac therapy.
  • There is limited knowledge about the optimal treatment for this neoplasm.
  • Our patient's favorable response to Gleevac therapy supports the concept of targeted molecular therapy in patients with c-kit-positive FATWO tumors.
  • [MeSH-major] Neoplasm Recurrence, Local / diagnosis. Peritoneal Neoplasms / diagnosis. Wolffian Ducts
  • [MeSH-minor] Abdominal Pain / etiology. Adolescent. Combined Modality Therapy. Diagnosis, Differential. Enzyme Inhibitors / therapeutic use. Female. Humans. Protein-Tyrosine Kinases / antagonists & inhibitors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15228432.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Enzyme Inhibitors; EC 2.7.10.1 / Protein-Tyrosine Kinases
  •  go-up   go-down


12. Redman R, Wilkinson EJ, Massoll NA: Uterine-like mass with features of an extrauterine adenomyoma presenting 22 years after total abdominal hysterectomy-bilateral salpingo-oophorectomy: a case report and review of the literature. Arch Pathol Lab Med; 2005 Aug;129(8):1041-3
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenomyoma is a benign tumor composed of smooth muscle and benign endometrium.
  • These tumors typically originate within the uterus.
  • The mass was pear-shaped with uterine-type smooth muscle and a cavity lined by functional endometrial glands and stroma.
  • Three involved the ovary, while one was located adjacent to the broad ligament with normal pelvic organs.
  • Although none of these other uterus-like masses were described as adenomyomas with uterine-like features, the histologic findings are strikingly similar.
  • An understanding of the müllerian system suggests that either an embryologic malformation or a differential multipotentiality existing in the subcoelomic tissues in response to hormonal stimulation results in a supernumerary müllerian structure like a uterus, as observed in this case.
  • The presence of endometrial glands and stroma in the mass confirms that the tissues in this mass are hormonally responsive.
  • It is most likely that this uterine-like mass arose from the tissues of the secondary müllerian system in response to estrogenic stimulation.
  • [MeSH-major] Adenomyoma / pathology. Gynecologic Surgical Procedures. Neoplasms, Hormone-Dependent / diagnosis. Uterine Neoplasms / pathology. Uterus / pathology
  • [MeSH-minor] Estrogen Replacement Therapy / adverse effects. Fallopian Tubes / surgery. Female. Humans. Hysterectomy. Middle Aged. Mullerian Ducts / drug effects. Mullerian Ducts / pathology. Ovariectomy

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16048397.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Ahuja S, Gaunt M, Crawford R: The use of Palma's procedure in the salvage therapy for a leiomyosarcoma of the right pelvic sidewall: an intraoperative multidisciplinary approach. Int J Gynecol Cancer; 2005 Jan-Feb;15(1):175-9
Genetic Alliance. consumer health - Leiomyosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The use of Palma's procedure in the salvage therapy for a leiomyosarcoma of the right pelvic sidewall: an intraoperative multidisciplinary approach.
  • Leiomyosarcomas of the ovary and broad ligament are relatively rare.
  • Less than 50 cases of primary ovarian and broad ligament leiomyosarcomas have been reported.
  • It is difficult to determine the exact role of surgery, chemotherapy, and radiotherapy in the management of these tumors.
  • So far, no cases of ovarian or broad ligament leiomyosarcomas have been reported where primary surgery for the sarcoma had to be combined with a Palma's procedure.
  • Resection of the pelvic mass was carried out and a Palma's procedure was performed by the vascular surgeon.
  • Chemotherapy was given postoperatively.
  • [MeSH-minor] Combined Modality Therapy. Female. Gynecologic Surgical Procedures. Humans. Middle Aged. Patient Care Team. Pelvis. Salvage Therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15670315.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Rajan DK, Soulen MC, Clark TW, Baum RA, Haskal ZJ, Shlansky-Goldberg RD, Freiman DB: Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization. J Vasc Interv Radiol; 2001 Feb;12(2):187-93
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary tumors included 11 gastrointestinal leiomyosarcomas, two splenic angiosarcomas, one leiomyosarcoma of the broad ligament, one leiomyosarcoma of the inferior vena cava, and one malignant fibrous histiocytoma of the colon.
  • Chemoembolization with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol particles was performed 1-5 times at approximately monthly intervals (mean, 2.8).
  • Pre- and posttreatment cross-sectional imaging was performed 1 month after completion of treatment and then every 3 months.
  • RESULTS: Two patients (13%) exhibited partial morphologic response, 11 patients (69%) were morphologically stable, and three (19%) demonstrated progression of disease 30 days after completion of treatment.
  • Among the 13 responders, two underwent partial hepatectomy after initial treatment.
  • Seven developed intrahepatic progression at a mean of 10 months and a median time of 8 months.
  • The remaining four patients had no documented intrahepatic progression at the time of last imaging follow-up.
  • Nine patients developed extrahepatic progression at a mean time of 6.3 months and a median time of 6 months, of whom four underwent additional surgical resection.
  • Response to therapy was based on time of first intervention.
  • Cumulative survival from time of diagnosis with use of Kaplan-Meier analysis was 81% at 1 year, 54% at 2 years, and 40% at 3 years.
  • Median survival time was 20 months.
  • Cumulative survival from initial chemoembolization was 67% at 1 year, 50% at 2 years, and 40% at 3 years, with a median survival time of 13 months.
  • CONCLUSION: Durable tumor response with chemoembolization is possible in this form of metastatic disease, which is highly resistant to systemic chemotherapy.
  • [MeSH-major] Chemoembolization, Therapeutic. Leiomyosarcoma / secondary. Leiomyosarcoma / therapy. Liver Neoplasms / secondary. Liver Neoplasms / therapy
  • [MeSH-minor] Cisplatin / administration & dosage. Disease Progression. Doxorubicin / administration & dosage. Ethiodized Oil / administration & dosage. Female. Follow-Up Studies. Humans. Male. Mitomycin / administration & dosage. Polyvinyl Alcohol / administration & dosage. Survival Rate. Time Factors

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. Ethiodol .
  • Hazardous Substances Data Bank. POLYVINYL ALCOHOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11265882.001).
  • [ISSN] 1051-0443
  • [Journal-full-title] Journal of vascular and interventional radiology : JVIR
  • [ISO-abbreviation] J Vasc Interv Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 50SG953SK6 / Mitomycin; 8008-53-5 / Ethiodized Oil; 80168379AG / Doxorubicin; 9002-89-5 / Polyvinyl Alcohol; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


15. Numnum TM, Leath CA 3rd, Straughn JM Jr, Conner MG, Barnes MN 3rd: Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy. Gynecol Oncol; 2005 May;97(2):713-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy.
  • BACKGROUND: Positron emission tomography (PET) is commonly used to detect occult or recurrent malignancy, including tumors of the female genital tract.
  • She had a history of molar pregnancy and persistent GTD requiring multi-agent chemotherapy.
  • Metastatic evaluation with computed tomography and magnetic resonance imaging showed no evidence of GTD.
  • A positron emission tomography/computed tomography (PET/CT) scan revealed a focus of metabolic activity in the left pelvis.
  • The patient underwent an exploratory laparotomy that revealed metastatic choriocarcinoma in the left broad ligament.
  • [MeSH-minor] Adult. Female. Humans. Pelvic Neoplasms / radionuclide imaging. Pelvic Neoplasms / secondary. Positron-Emission Tomography. Pregnancy. Pregnancy Outcome. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Choriocarcinoma.
  • Genetic Alliance. consumer health - Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15863190.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Karaca M, Sevinc A, Aydin A, Gocmen A, Buyukberber S, Camci C, Sari I: Female adnexal tumor of probable Wolffian origin diagnosed during the staging evaluation of extranodal diffuse large B-cell lymphoma. Leuk Lymphoma; 2005 Jun;46(6):929-33
Genetic Alliance. consumer health - Wolffian tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Female adnexal tumor of probable Wolffian origin diagnosed during the staging evaluation of extranodal diffuse large B-cell lymphoma.
  • Female adnexal tumor of probable Wolffian origin (FATPWO) is a rare neoplasm arising within the leaves of broad ligament or hanging from it or a fallopian tube.
  • A 55-year-old female patient with the diagnosis of non-Hodgkin lymphoma is presented.
  • The staging procedure revealed a pelvic mass that was not regressed by chemotherapy.
  • According to our knowledge, this is the first case of FATPWO coexisting with extranodal diffuse large B-cell lymphoma in the English-language literature.
  • [MeSH-major] Lymphoma, B-Cell / diagnosis. Lymphoma, Large B-Cell, Diffuse / diagnosis. Neoplasms, Adnexal and Skin Appendage / diagnosis. Wolffian Ducts / pathology
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cytoplasm / metabolism. Female. Humans. Lymphatic Metastasis. Middle Aged. Neoplasm Staging. Stomach Neoplasms / complications. Stomach Neoplasms / diagnosis. Stomach Neoplasms / therapy. Treatment Outcome

  • Genetic Alliance. consumer health - Large B cell diffuse lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16019541.001).
  • [ISSN] 1029-2403
  • [Journal-full-title] Leukemia & lymphoma
  • [ISO-abbreviation] Leuk. Lymphoma
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


17. Shone N, Duggan MA, Ghatage P: Granulosa cell tumour of the broad ligament. Pathology; 2003 Jun;35(3):265-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Granulosa cell tumour of the broad ligament.
  • [MeSH-major] Broad Ligament / pathology. Genital Neoplasms, Female / pathology. Granulosa Cell Tumor / secondary. Peritoneal Neoplasms / pathology
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biomarkers, Tumor / analysis. Chemotherapy, Adjuvant. Female. Humans. Immunohistochemistry. Neoplasm Recurrence, Local / drug therapy. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Palliative Care

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14506976.001).
  • [ISSN] 0031-3025
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down






Advertisement